Follow The Filings

ZURA Zura Bio Ltd.

Health Care, filed as ZURA BIO LTD (CLASS A ORD SHS), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by ZURA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ZURA insider trades
  • $12.5M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. AI Biotechnology LLC 10% owner, +3 joint filers
    Buy
    $12.5M 2,000,000 shares at $6.25 +44% to stake
    Traded Feb 26 Filed Mar 2
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 5.02 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,2.02,8.01,9.01 Filing Doc
8-K/A 9.01 Filing Doc
424B5 Filing Doc

Source: SEC EDGAR submissions, updated 10 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$60.36M -$52.4M -$68.65M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $100.84M $178.74M $112.31M
Total non-current assets * $0M $0.789M $1.64M
Total assets $100.84M $179.53M $113.95M
Total current liabilities $20.3M $19.51M $12.41M
Total non-current liabilities * $990,000 $0.00 $0.00
Total equity $59.33M $146.82M $101.54M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$15.05M -$28.08M -$64.82M
Cash from investing -$8M -$5.08M -$0.113M
Cash from financing $121.29M $109.84M -$2.16M
Net change in cash * $98.24M $76.69M -$67.09M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf